U.S. RESEARCH ROUNDUP- Akoya Biosciences, Boston Beer Company, Victory Capital Holdings

Boston Beer

14/05/2024 08:20

May 14 (Reuters) - Wall Street securities analysts revised their ratings and price
targets on several U.S.-listed companies, including Akoya Biosciences, Boston Beer Company and
Victory Capital Holdings on Tuesday. 
    
  HIGHLIGHTS   
             
  
                 * Akoya Biosciences Inc  AKYA.O : Canaccord Genuity cuts target price to $6
 from $10  
 
                 * Boston Beer Company Inc  SAM.N : Jefferies raises target price to $360 from
 $335
 
                 * Fortrea Holdings Inc  FTRE.O : Evercore ISI cuts target price to $31 from
 $43  
 
                 * Medical Properties Trust Inc  MPW.N : RBC cuts to sector perform from
 outperform
 
                 * Victory Capital Holdings Inc  VCTR.O : RBC raises target price to $56 from
 $47
 
           
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday.
Stock entries are in alphabetical order. 
    
                 * Agilon Health Inc  AGL.N : Jefferies cuts target price to $5.75 from $6.5
 
                 * Akoya Biosciences Inc  AKYA.O : BTIG cuts target price to $6 from $9
 
                 * Akoya Biosciences Inc  AKYA.O : Canaccord Genuity cuts target price to $6 from $10
 
                 * Akoya Biosciences Inc  AKYA.O : JP Morgan cuts target price to $7 from $10
 
                 * Applied DNA Sciences Inc  APDN.O : Maxim Group cuts to hold from buy
 
                 * Arcellx Inc  ACLX.O : Evercore ISI initiates coverage with outperform rating; PT $85
 
                 * Aris Water Solutions Inc  ARIS.N : Evercore ISI raises target price to $20 from $16
 
                 * Atlanticus Holdings Corp  ATLC.O : Jefferies cuts target price to $40 from $50
 
                 * Biomarin Pharmaceutical  BMRN.O : Evercore ISI initiates with outperform rating; PT $113
 
                 * Blue Owl Capital Corp  OBDC.N : KBW cuts to market perform from outperform
 
                 * Boston Beer Company Inc  SAM.N : Jefferies raises target price to $360 from $335
 
                 * Boston Beer Company Inc  SAM.N : Jefferies raises to buy from hold
 
                 * Bridgebio Pharma  BBIO.O : Evercore ISI initiates coverage with outperform rating; PT $50            
 
 
                 * Brighthouse Financial Inc  BHF.O : KBW cuts target price to $48 from $50
 
                 * Caredx Inc  CDNA.O : Raymond James cuts to market perform from outperform
 
                 * Caretrust REIT Inc  CTRE.N : Jefferies raises target price to $28 from $27
 
                 * Chuy's Holdings Inc  CHUY.O : Stifel cuts target price to $32 from $36
 
                 * Civista Bancshares Inc  CIVB.O : D.A. Davidson cuts target price by $4 to $17
 
                 * Clearway Energy Inc  CWENa.N : Evercore ISI raises target price to $30 from $25
 
                 * Compass Therapeutics Inc.  CMPX.O : Jefferies cuts target price to $7 from $8
 
                 * Compass Therapeutics Inc.  CMPX.O : Leerink Partners cuts target price to $10 from $11
 
                 * Constellation Brands Inc  STZ.N : Jefferies cuts target price to $311 from $314
 
                 * Definitive Healthcare Corp  DH.O : Jefferies cuts target price to $10 from $12
 
                 * Emerson  EMR.N : Berenberg raises target price to $133 from $130
 
                 * Five Below Inc  FIVE.O : Jefferies cuts target price to $200 from $215
 
                 * Fortrea Holdings Inc  FTRE.O : Evercore ISI cuts target price to $31 from $43
 
                 * Fulcrum Therapeutics Inc  FULC.O : Leerink Partners raises target price to $16 from $14
 
                 * Green Plains Inc  GPRE.O : Jefferies cuts target price to $37 from $45
 
                 * Inotiv Inc  NOTV.O : Jefferies cuts target price to $3.75 from $11.5
 
                 * Inotiv Inc  NOTV.O : Jefferies cuts to hold from buy
 
                 * Iovance Biotherapeutics Inc  IOVA.O : Truist Securities cuts PT to $25 from $26
 
                 * Jackson Financial Inc  JXN.N : KBW cuts to market perform from outperform
 
                 * Jackson Financial Inc  JXN.N : KBW raises target price to $80 from $75
 
                 * Jeld-Wen Holding Inc  JELD.N : Jefferies cuts target price to $16 from $20
 
                 * Legend Biotech Corp  LEGN.O : Jefferies raises target price to $94 from $93
 
                 * Legend Biotech Corp  LEGN.O : RBC raises target price to $86 from $85
 
                 * Live Oak Bancshares Inc  LOB.N : Truist Securities raises target price to $40 from $38
 
                 * Madison Square Garden Entertainment Corp  MSGE.N : Macquarie raises PT to $46 from $45
 
                 * Medical Properties Trust Inc  MPW.N : RBC cuts to sector perform from outperform
 
                 * Moderna  MRNA.O : Evercore ISI initiates coverage with in line rating; price target $120
 
                 * National Health Investors Inc  NHI.N : Jefferies raises target price to $63 from $54
 
                 * Nelnet Inc  NNI.N : TD Cowen raises target price to $96 from $90
 
                 * Neurocrine Biosciences  NBIX.O : Evercore ISI initiates with outperform rating; PT $175
 
                 * Neurogene Inc  NGNE.O : Leerink Partners cuts target price to $45 from $46
 
                 * Novabay Pharmaceuticals Inc  NBY.A : Ascendiant Capital Markets cuts PT to $1.75 from $2
 
                 * Orange County Bancorp Inc  OBT.O : Stephens cuts target price to $53 from $56
 
                 * Palo Alto Networks Inc  PANW.O : Evercore ISI adds stock to its tactical underperform list
 
                 * Palo Alto Networks Inc  PANW.O : Evercore ISI cuts target price to $385 from $405
 
                 * Perspective Therapeutics  CATX.A : RBC initiates coverage With Outperform rating; PT $3
 
                 * Plains All American Pipeline LP  PAA.O : RBC raises target price to $18 from $17                   
 
                 * Planet Fitness Inc  PLNT.N : JP Morgan raises target price to $78 from $68
 
                 * Planet Fitness Inc  PLNT.N : JP Morgan raises to overweight from neutral
 
                 * Primerica Inc  PRI.N : KBW cuts target price to $255 from $260
 
                 * Regeneron Pharmaceuticals  REGN.O : Evercore ISI initiates coverage with outperform rating 
 
                 * Regeneron Pharmaceuticals  REGN.O : Evercore ISI initiates coverage with PT $1150
 
                 * Roblox Corp  RBLX.N : Roth MKM cuts target price to $35 from $55
 
                 * Roblox Corp  RBLX.N : Roth MKM cuts to neutral from buy
 
                 * SLB  SLB.N : zephirin Group raises price objective to $59 from $57
 
                 * Sphere Entertainment Co  SPHR.N : Macquarie cuts target price to $38 from $40
 
                 * Squarespace Inc  SQSP.N : Raymond James cuts to market perform from outperform
 
                 * Taysha Gene Therapies Inc  TSHA.O : Jefferies raises target price to $8 from $2
 
                 * Taysha Gene Therapies Inc  TSHA.O : Jefferies raises to buy from hold
 
                 * Terreno Realty Corp  TRNO.N : Jefferies raises target price to $89 from $87
 
                 * Territorial Bancorp Inc  TBNK.O : KBW cuts target price to $9.66 from $10
 
                 * Trex Co Inc  TREX.N : JP Morgan raises target price to $95 from $93
 
                 * United Bankshares Inc  UBSI.O : Stephens raises target price to $36 from $34
 
                 * Verb Technology Company  VERB.O : Ascendiant Capital Markets cuts PT to $4.50 from $5
 
                 * Verrica Pharmaceuticals Inc  VRCA.O : Needham raises target price to $16 from $8
 
                 * Victory Capital Holdings Inc  VCTR.O : RBC raises target price to $56 from $47
 
 
                    
    

 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))